Penumbra (PEN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Stifel Maintains Penumbra(PEN.US) With Buy Rating, Maintains Target Price $238
Moomoo NewsOct 31 09:40 ET · Ratings
A Quick Look at Today's Ratings for Penumbra(PEN.US), With a Forecast Between $232 to $248
Moomoo NewsOct 31 09:00 ET · Ratings
Needham Reiterates Hold on Penumbra
BenzingaOct 31 08:33 ET
Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market
Zacks Oct 31 08:00 ET
Penumbra Is Maintained at Outperform by Baird
Dow JonesOct 31 08:00 ET · Ratings
Baird Maintains Outperform on Penumbra, Raises Price Target to $248
BenzingaOct 31 07:50 ET · Ratings

Comments

Moomoo AI

Feb 22 11:42

Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Chatterbox Moo

Nov 21, 2023 04:20

Columns Medical-device Stock Selloff Caused by Ozempic Fears Has Gone Too Far—Now They're Rebounding

A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say.
To be sure, drugs such as $Novo-Nordisk A/S (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...

11

Moomoo AI

Nov 9, 2023 05:00

Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.

The Strong Earnings Posted By Penumbra (NYSE:PEN) Are A Good Indication Of The Strength Of The Business

Moomoo AI

Nov 3, 2023 12:00

Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.